Michael Hoffmeister1, Bernd Holleczek, Nadine Zwink, Christian Stock, Christa Stegmaier, Hermann Brenner. 1. Department of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg; Cancer Registry Saarland, Saarbrücken; Institute for Medical Biometrics and Information Science, University of Heidelberg; Department of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg.
Abstract
BACKGROUND: Participation rates in bowel cancer screening programs in Germany continue to be low. In a model project, a logistically simple procedure for inviting patients to participate was tested as a means of increasing participation. METHODS: A randomized trial was performed involving persons residing in the German federal state of Saarland who had either their 50th or their 55th birthday in the year beginning on 1 April 2012 (18 560 and 16 824 persons, respectively). The 50-year-olds received a written invitation to undergo a test for blood in the stool, either with or without a stool test attached, or else no invitation at all. The 55-year-olds received either an invitation to undergo colonoscopy or no invitation. Participation rates within one year were determined from billing data of the Saarland Association of Statutory Health. Insurance Physicians. The trial was registered in the German Registry of Clinical Trials, no. DRKS00006098. RESULTS: A written invitation to undergo testing of the stool for blood, together with an accompanying test, increased the participation rate within one year by 62% (from 15% to 25%, p <0.001, especially among men (+158% vs. +39% for women). The participation rate was higher in general among women than among men (33% vs. 17%). On the other hand, a written invitation with no accompanying test did not increase the participation rate. A written invitation to undergo colonoscopic screening increased the participation rate within one year by 32% (5.9% vs 4.4%, p <0.001). CONCLUSION: Targeted invitations can markedly increase participation rates in cancer screening. Written invitations to undergo stool testing for blood should be accompanied by an actual test. Further trials should also include information about the number of adenomas and carcinomas detected by screening.
RCT Entities:
BACKGROUND: Participation rates in bowel cancer screening programs in Germany continue to be low. In a model project, a logistically simple procedure for inviting patients to participate was tested as a means of increasing participation. METHODS: A randomized trial was performed involving persons residing in the German federal state of Saarland who had either their 50th or their 55th birthday in the year beginning on 1 April 2012 (18 560 and 16 824 persons, respectively). The 50-year-olds received a written invitation to undergo a test for blood in the stool, either with or without a stool test attached, or else no invitation at all. The 55-year-olds received either an invitation to undergo colonoscopy or no invitation. Participation rates within one year were determined from billing data of the Saarland Association of Statutory Health. Insurance Physicians. The trial was registered in the German Registry of Clinical Trials, no. DRKS00006098. RESULTS: A written invitation to undergo testing of the stool for blood, together with an accompanying test, increased the participation rate within one year by 62% (from 15% to 25%, p <0.001, especially among men (+158% vs. +39% for women). The participation rate was higher in general among women than among men (33% vs. 17%). On the other hand, a written invitation with no accompanying test did not increase the participation rate. A written invitation to undergo colonoscopic screening increased the participation rate within one year by 32% (5.9% vs 4.4%, p <0.001). CONCLUSION: Targeted invitations can markedly increase participation rates in cancer screening. Written invitations to undergo stool testing for blood should be accompanied by an actual test. Further trials should also include information about the number of adenomas and carcinomas detected by screening.
Authors: Hermann Brenner; Jenny Chang-Claude; Christoph M Seiler; Alexander Rickert; Michael Hoffmeister Journal: Ann Intern Med Date: 2011-01-04 Impact factor: 25.391
Authors: I Stegeman; S C van Doorn; M W Mundt; R C Mallant-Hent; E Bongers; M A G Elferink; P Fockens; A K Stroobants; P M Bossuyt; E Dekker Journal: Cancer Epidemiol Date: 2015-04-21 Impact factor: 2.984
Authors: Hermann Brenner; Petra Schrotz-King; Bernd Holleczek; Alexander Katalinic; Michael Hoffmeister Journal: Dtsch Arztebl Int Date: 2016-02-19 Impact factor: 5.594
Authors: S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish Journal: N Engl J Med Date: 1993-12-30 Impact factor: 91.245
Authors: Christian von Wagner; Gianluca Baio; Rosalind Raine; Julia Snowball; Stephen Morris; Wendy Atkin; Austin Obichere; Graham Handley; Richard F Logan; Sandra Rainbow; Stephen Smith; Stephen Halloran; Jane Wardle Journal: Int J Epidemiol Date: 2011-02-17 Impact factor: 7.196
Authors: Alexander Bauer; Jürgen F Riemann; Thomas Seufferlein; Max Reinshagen; Stephan Hollerbach; Ulrike Haug; Susanne Unverzagt; Stephanie Boese; Madeleine Ritter-Herschbach; Patrick Jahn; Thomas Frese; Michael Harris; Margarete Landenberger Journal: Dtsch Arztebl Int Date: 2018-10-26 Impact factor: 5.594
Authors: K Stratmann; H Bock; N Filmann; P Fister; C Weber; W Tacke; B Simonis; M Höftmann; O Schröder; J Hausmann; S Zeuzem; I Blumenstein Journal: United European Gastroenterol J Date: 2018-04-16 Impact factor: 4.623
Authors: Koshi Takahashi; Sho Nakamura; Kaname Watanabe; Masahiko Sakaguchi; Hiroto Narimatsu Journal: Int J Environ Res Public Health Date: 2022-09-12 Impact factor: 4.614
Authors: Laura F Gruner; Efrat L Amitay; Thomas Heisser; Feng Guo; Tobias Niedermaier; Anton Gies; Michael Hoffmeister; Hermann Brenner Journal: Cancers (Basel) Date: 2021-03-25 Impact factor: 6.639